MedPath

Alliance for Clinical Trials in Oncology

Alliance for Clinical Trials in Oncology logo
🇺🇸United States
Ownership
Private
Established
2011-01-01
Employees
251
Market Cap
-
Website
https://www.allianceforclinicaltrialsinoncology.org

Acute Pain Caused by Paclitaxel in Patients With Cancer

Completed
Conditions
Neurotoxicity
Pain
Unspecified Adult Solid Tumor, Protocol Specific
Chemotherapeutic Agent Toxicity
Interventions
Behavioral: pain questionnaires
First Posted Date
2009-03-11
Last Posted Date
2016-07-14
Lead Sponsor
Alliance for Clinical Trials in Oncology
Target Recruit Count
306
Registration Number
NCT00860041
Locations
🇺🇸

Mason District Hospital, Havana, Illinois, United States

🇺🇸

Michiana Hematology-Oncology, PC - Elkhart, Elkhart, Indiana, United States

🇺🇸

Doctors Hospital at Ohio Health, Columbus, Ohio, United States

and more 272 locations

Sorafenib and Bevacizumab in Treating Patients With Metastatic Colorectal Cancer

Phase 2
Completed
Conditions
Recurrent Colon Cancer
Recurrent Rectal Cancer
Stage IV Colon Cancer
Stage IV Rectal Cancer
Interventions
Biological: bevacizumab
First Posted Date
2009-01-22
Last Posted Date
2017-09-06
Lead Sponsor
Alliance for Clinical Trials in Oncology
Target Recruit Count
83
Registration Number
NCT00826540
Locations
🇺🇸

Graham Hospital Association, Canton, Illinois, United States

🇺🇸

Elkhart General Hospital, Elkhart, Indiana, United States

🇺🇸

Siouxland Hematology Oncology Associates, Sioux City, Iowa, United States

and more 207 locations

Docetaxel, Carboplatin, Trastuzumab, and Lapatinib in Treating Patients With Early Stage Breast Cancer

Phase 2
Completed
Conditions
Breast Cancer
Interventions
First Posted Date
2009-01-12
Last Posted Date
2019-10-21
Lead Sponsor
Alliance for Clinical Trials in Oncology
Target Recruit Count
30
Registration Number
NCT00820872
Locations
🇺🇸

Cancer Center of Kansas-Independence, Independence, Kansas, United States

🇺🇸

Bismarck Cancer Center, Bismarck, North Dakota, United States

🇺🇸

Kalispell Regional Medical Center, Kalispell, Montana, United States

and more 130 locations

Pemetrexed, Carboplatin, and Bevacizumab as First-Line Therapy in Treating Older Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

Phase 2
Completed
Conditions
Lung Cancer
Interventions
First Posted Date
2008-11-26
Last Posted Date
2017-01-25
Lead Sponsor
Alliance for Clinical Trials in Oncology
Target Recruit Count
65
Registration Number
NCT00798603
Locations
🇺🇸

Illinois CancerCare - Princeton, Princeton, Illinois, United States

🇺🇸

Memorial Hospital of South Bend, South Bend, Indiana, United States

🇺🇸

CCOP - Northern Indiana CR Consortium, South Bend, Indiana, United States

and more 212 locations

Rituximab, Cladribine, and Temsirolimus in Treating Patients With Newly Diagnosed Mantle Cell Lymphoma

Phase 1
Completed
Conditions
Lymphoma
Interventions
Biological: rituximab
Biological: Filgrastim
Biological: Pegfilgrastim
First Posted Date
2008-11-10
Last Posted Date
2018-01-09
Lead Sponsor
Alliance for Clinical Trials in Oncology
Target Recruit Count
74
Registration Number
NCT00787969
Locations
🇺🇸

Elkhart General Hospital, Elkhart, Indiana, United States

🇺🇸

Bismarck Cancer Center, Bismarck, North Dakota, United States

🇺🇸

St. Alexius Medical Center Cancer Center, Bismarck, North Dakota, United States

and more 141 locations

Radiation Therapy or Observation After Chemotherapy in Treating Patients With Stage IV Non-Small Cell Lung Cancer

Phase 2
Terminated
Conditions
Lung Cancer
Interventions
Other: clinical observation
Radiation: radiation therapy
First Posted Date
2008-10-20
Last Posted Date
2017-03-06
Lead Sponsor
Alliance for Clinical Trials in Oncology
Target Recruit Count
3
Registration Number
NCT00776100
Locations
🇺🇸

Cancer Center of Kansas-Independence, Independence, Kansas, United States

🇺🇸

Lahey Clinic Medical Center - Burlington, Burlington, Massachusetts, United States

🇺🇸

Saint Francis/Mount Sinai Regional Cancer Center at Saint Francis Hospital and Medical Center, Hartford, Connecticut, United States

and more 162 locations

Panitumumab, Docetaxel, Cisplatin, Radiation Therapy, and Surgery in Treating Patients With Newly Diagnosed, Locally Advanced Esophageal Cancer or Cancer of the Gastroesophageal Junction

Phase 2
Completed
Conditions
Adenocarcinoma of the Gastroesophageal Junction
Esophageal Cancer
Interventions
Biological: panitumumab
Procedure: neoadjuvant therapy
Procedure: therapeutic conventional surgery
Radiation: radiation therapy
First Posted Date
2008-09-23
Last Posted Date
2016-03-11
Lead Sponsor
Alliance for Clinical Trials in Oncology
Target Recruit Count
70
Registration Number
NCT00757172
Locations
🇺🇸

Good Samaritan Hospital, Dayton, Ohio, United States

🇺🇸

Curtis and Elizabeth Anderson Cancer Institute at Memorial Health University Medical Center, Savannah, Georgia, United States

🇺🇸

Robert H. Lurie Comprehensive Cancer Center at Northwestern University, Chicago, Illinois, United States

and more 18 locations

Gemcitabine and Erlotinib Before and After Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery

Phase 2
Completed
Conditions
Pancreatic Cancer
Interventions
Procedure: therapeutic conventional surgery
First Posted Date
2008-08-13
Last Posted Date
2019-10-21
Lead Sponsor
Alliance for Clinical Trials in Oncology
Target Recruit Count
123
Registration Number
NCT00733746
Locations
🇺🇸

Rebecca and John Moores UCSD Cancer Center, La Jolla, California, United States

🇺🇸

Chao Family Comprehensive Cancer Center at University of California Irvine Medical Center, Orange, California, United States

🇺🇸

Lakeland Regional Cancer Center at Lakeland Regional Medical Center, Lakeland, Florida, United States

and more 21 locations

Laparoscopic-Assisted Resection or Open Resection in Treating Patients With Rectal Cancer

Phase 3
Completed
Conditions
Colorectal Cancer
Interventions
Procedure: Open laparotomy and rectal resection
Procedure: Laparoscopic-assisted rectal resection
First Posted Date
2008-08-01
Last Posted Date
2020-05-07
Lead Sponsor
Alliance for Clinical Trials in Oncology
Target Recruit Count
486
Registration Number
NCT00726622
Locations
🇺🇸

Evanston Hospital, Evanston, Illinois, United States

🇨🇦

St. Joseph's Hospital - Charlton Campus, Hamilton, Ontario, Canada

🇺🇸

Stony Brook University Cancer Center, Stony Brook, New York, United States

and more 34 locations

Cryoablation Therapy in Treating Patients With Invasive Ductal Breast Cancer

Phase 2
Conditions
Breast Cancer
Interventions
Procedure: cryosurgery
Procedure: therapeutic conventional surgery
First Posted Date
2008-07-28
Last Posted Date
2017-08-14
Lead Sponsor
Alliance for Clinical Trials in Oncology
Target Recruit Count
99
Registration Number
NCT00723294
Locations
🇺🇸

Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, Indiana, United States

🇺🇸

Henry Ford Hospital, Detroit, Michigan, United States

🇺🇸

Bellingham Breast Center, Bellingham, Washington, United States

and more 13 locations
© Copyright 2025. All Rights Reserved by MedPath